To determine whether the resveratrol-induced inhibition of NAF-1 increases the susceptibility of pancreatic cancer cells to gemcitabine, we treated the Panc-1 and Mia paca-2 cells with a combination of 50 μM resveratrol and 2 μM gemcitabine, and the MTT assay was performed. Here, NAF1 is linked to familial pancreatic carcinoma.